A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer

NCT06485271 · clinicaltrials.gov ↗

RECRUITING

Status

504

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
RWS
PD-1 Immunotherapy

Interventions

DRUG: Camrelizumab
DRUG: apatinib
DRUG: chemotherapy

Sponsor

Changzhi People's Hospital Affiliated to Changzhi Medical College